Which liquid biopsy analytes have the highest potential for improved patient stratification in clinical trials within the next 5 years?

Vote below
129 votes
Cell-free DNA
45%
85 votes
Circulating tumor cells
30%
34 votes
Exosomes / extracellular vesicles
12%
15 votes
Cell-free RNA / miRNA
5%
22 votes
Multiple analytes
8%